• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Editorial: Novel treatments for cardiovascular diseases by targeting inflammation, oxidative stress, and cell death.

作者信息

Fan Dong, Wang Li, Chakraborty Abhijit, Zhang Cheng-Lin, Yang Feng Hua

机构信息

Department of Pathophysiology, Zhuhai Campus of Zunyi Medical University, Zhuhai, China.

Department of Biomedical Sciences, City University of Hong Kong, Hong Kong, Hong Kong SAR, China.

出版信息

Front Cardiovasc Med. 2025 Jan 7;11:1538222. doi: 10.3389/fcvm.2024.1538222. eCollection 2024.

DOI:10.3389/fcvm.2024.1538222
PMID:39844902
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11752895/
Abstract
摘要

相似文献

1
Editorial: Novel treatments for cardiovascular diseases by targeting inflammation, oxidative stress, and cell death.社论：通过靶向炎症、氧化应激和细胞死亡治疗心血管疾病的新方法
Front Cardiovasc Med. 2025 Jan 7;11:1538222. doi: 10.3389/fcvm.2024.1538222. eCollection 2024.
2
Oxidative Stress and Antioxidant Treatments in Cardiovascular Diseases.心血管疾病中的氧化应激与抗氧化治疗
Antioxidants (Basel). 2020 Dec 17;9(12):1292. doi: 10.3390/antiox9121292.
3
Editorial: Natural products targeting oxidative stress and cell death: Treatment potential in metabolic and cardiovascular diseases.社论：针对氧化应激和细胞死亡的天然产物：在代谢性疾病和心血管疾病中的治疗潜力。
Front Pharmacol. 2023 Feb 1;14:1141878. doi: 10.3389/fphar.2023.1141878. eCollection 2023.
4
Ferroptosis: a cell death connecting oxidative stress, inflammation and cardiovascular diseases.铁死亡：一种连接氧化应激、炎症与心血管疾病的细胞死亡方式。
Cell Death Discov. 2021 Jul 26;7(1):193. doi: 10.1038/s41420-021-00579-w.
5
Hydrogen Sulfide: A Gaseous Mediator and Its Key Role in Programmed Cell Death, Oxidative Stress, Inflammation and Pulmonary Disease.硫化氢：一种气体介质及其在程序性细胞死亡、氧化应激、炎症和肺部疾病中的关键作用。
Antioxidants (Basel). 2022 Oct 31;11(11):2162. doi: 10.3390/antiox11112162.
6
Physical Exercise Potentially Targets Epicardial Adipose Tissue to Reduce Cardiovascular Disease Risk in Patients with Metabolic Diseases: Oxidative Stress and Inflammation Emerge as Major Therapeutic Targets.体育锻炼可能针对心外膜脂肪组织以降低代谢性疾病患者的心血管疾病风险：氧化应激和炎症成为主要治疗靶点。
Antioxidants (Basel). 2021 Nov 4;10(11):1758. doi: 10.3390/antiox10111758.
7
Targeting Metabolic Diseases: The Role of Nutraceuticals in Modulating Oxidative Stress and Inflammation.靶向代谢疾病：营养保健品在调节氧化应激和炎症中的作用。
Nutrients. 2024 Feb 10;16(4):507. doi: 10.3390/nu16040507.
8
Role of inflammation and oxidative stress in endothelial progenitor cell function and mobilization: therapeutic implications for cardiovascular diseases.炎症和氧化应激在内皮祖细胞功能及动员中的作用：对心血管疾病的治疗意义
Atherosclerosis. 2008 Dec;201(2):236-47. doi: 10.1016/j.atherosclerosis.2008.05.034. Epub 2008 May 28.
9
Oxidative Stress and Inflammation in Cardiovascular Diseases and Cancer: Role of Non-coding RNAs.氧化应激与心血管疾病和癌症中的炎症：非编码 RNA 的作用。
Yale J Biol Med. 2022 Mar 31;95(1):129-152. eCollection 2022 Mar.
10
Early growth response-1: Key mediators of cell death and novel targets for cardiovascular disease therapy.早期生长反应因子-1：细胞死亡的关键介质及心血管疾病治疗的新靶点
Front Cardiovasc Med. 2023 Mar 28;10:1162662. doi: 10.3389/fcvm.2023.1162662. eCollection 2023.

本文引用的文献

1
"Anti-inflammatory Therapies in Atherosclerosis - Where are we going?".动脉粥样硬化中的抗炎疗法——我们将何去何从？
Curr Atheroscler Rep. 2024 Dec 19;27(1):19. doi: 10.1007/s11883-024-01267-7.
2
Targeted Delivery and ROS-Responsive Release of Lutein Nanoassemblies Inhibit Myocardial Ischemia-Reperfusion Injury by Improving Mitochondrial Function.叶黄素纳米组装体的靶向递送和 ROS 响应性释放通过改善线粒体功能抑制心肌缺血再灌注损伤。
Int J Nanomedicine. 2024 Nov 19;19:11973-11996. doi: 10.2147/IJN.S488532. eCollection 2024.
3
Atherosclerosis, calcific aortic valve disease and mitral annular calcification: same or different?动脉粥样硬化、钙化性主动脉瓣疾病和二尖瓣环钙化：相同还是不同？
Int J Cardiol. 2025 Feb 1;420:132741. doi: 10.1016/j.ijcard.2024.132741. Epub 2024 Nov 16.
4
Mechanisms of the septic heart: From inflammatory response to myocardial edema.脓毒症性心脏的发生机制：从炎症反应到心肌水肿。
J Mol Cell Cardiol. 2024 Oct;195:73-82. doi: 10.1016/j.yjmcc.2024.08.003. Epub 2024 Aug 13.
5
TLR4 signalling in ischemia/reperfusion injury: a promising target for linking inflammation, oxidative stress and programmed cell death to improve organ transplantation outcomes.TLR4 信号在缺血/再灌注损伤中的作用：将炎症、氧化应激和程序性细胞死亡联系起来以改善器官移植结果的有希望的靶点。
Front Immunol. 2024 Jul 18;15:1447060. doi: 10.3389/fimmu.2024.1447060. eCollection 2024.
6
Clinical implications of septic cardiomyopathy: A narrative review.脓毒症性心肌病的临床意义：一篇叙述性综述。
Medicine (Baltimore). 2024 Apr 26;103(17):e37940. doi: 10.1097/MD.0000000000037940.
7
2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association.2024 年心脏病与中风统计数据：美国心脏协会发布的美国和全球数据报告。
Circulation. 2024 Feb 20;149(8):e347-e913. doi: 10.1161/CIR.0000000000001209. Epub 2024 Jan 24.
8
Ischemia-reperfusion injury: molecular mechanisms and therapeutic targets.缺血再灌注损伤：分子机制与治疗靶点。
Signal Transduct Target Ther. 2024 Jan 8;9(1):12. doi: 10.1038/s41392-023-01688-x.
9
Novel therapeutic targets and emerging treatments for atherosclerotic cardiovascular disease.动脉粥样硬化性心血管疾病的新型治疗靶点与新兴治疗方法
Eur Heart J Cardiovasc Pharmacother. 2024 Jan 5;10(1):53-67. doi: 10.1093/ehjcvp/pvad074.
10
Septic Cardiomyopathy: From Pathophysiology to the Clinical Setting.脓毒症性心肌病：从病理生理学到临床环境。
Cells. 2022 Sep 11;11(18):2833. doi: 10.3390/cells11182833.